David L. Sultzer

13.0k total citations · 4 hit papers
110 papers, 7.0k citations indexed

About

David L. Sultzer is a scholar working on Psychiatry and Mental health, Physiology and Cognitive Neuroscience. According to data from OpenAlex, David L. Sultzer has authored 110 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Psychiatry and Mental health, 31 papers in Physiology and 26 papers in Cognitive Neuroscience. Recurrent topics in David L. Sultzer's work include Dementia and Cognitive Impairment Research (65 papers), Schizophrenia research and treatment (32 papers) and Alzheimer's disease research and treatments (27 papers). David L. Sultzer is often cited by papers focused on Dementia and Cognitive Impairment Research (65 papers), Schizophrenia research and treatment (32 papers) and Alzheimer's disease research and treatments (27 papers). David L. Sultzer collaborates with scholars based in United States, Canada and Australia. David L. Sultzer's co-authors include Jeffrey L. Cummings, Michael E. Mahler, George Bartzokis, Jim Mintz, M. Mandelkern, Constantine G. Lyketsos, Keith H. Nuechterlein, Dylan G. Harwood, Pierre N. Tariot and Rebecca J. Melrose and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Psychiatry.

In The Last Decade

David L. Sultzer

107 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

2006 760 citations Lon S. Schneider, Pierre N. Tariot et al. profile →
Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment

2015 517 citations Zahinoor Ismail, Eric E. Smith et al. Alzheimer s & Dementia profile →
Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults

2011 395 citations David L. Sultzer et al. profile →
The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations

2017 322 citations Zahinoor Ismail, Luis Agüera-Ortíz et al. Journal of Alzheimer s Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David L. Sultzer United States	41	4.2k	1.8k	1.5k	734	697	110	7.0k
Paul B. Rosenberg United States	42	3.7k 0.9×	2.0k 1.1×	1.3k 0.9×	860 1.2×	557 0.8×	174	7.2k
Philip S. Insel United States	39	4.5k 1.1×	3.3k 1.8×	1.6k 1.1×	894 1.2×	601 0.9×	110	7.0k
Robert A. Sweet United States	58	4.2k 1.0×	2.7k 1.5×	1.9k 1.3×	786 1.1×	669 1.0×	246	9.8k
Eugene H. Rubin United States	36	4.5k 1.1×	2.7k 1.5×	1.3k 0.9×	823 1.1×	520 0.7×	92	7.9k
Angelo Bianchetti Italy	47	3.2k 0.8×	2.3k 1.3×	1.4k 1.0×	639 0.9×	815 1.2×	178	7.8k
Zahinoor Ismail Canada	49	6.1k 1.5×	2.1k 1.2×	1.8k 1.2×	658 0.9×	942 1.4×	317	8.9k
Judith Saxton United States	42	3.6k 0.9×	2.0k 1.1×	1.4k 1.0×	634 0.9×	424 0.6×	105	6.0k
Gad A. Marshall United States	47	4.2k 1.0×	3.1k 1.7×	2.4k 1.7×	905 1.2×	418 0.6×	159	7.4k
Helen Lavretsky United States	47	2.7k 0.6×	1.8k 1.0×	2.0k 1.3×	573 0.8×	442 0.6×	216	9.9k
Marilyn Albert United States	45	3.1k 0.7×	1.9k 1.1×	1.3k 0.9×	581 0.8×	416 0.6×	104	6.5k

Countries citing papers authored by David L. Sultzer

Since Specialization

Citations

This map shows the geographic impact of David L. Sultzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Sultzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Sultzer more than expected).

Fields of papers citing papers by David L. Sultzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Sultzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Sultzer. The network helps show where David L. Sultzer may publish in the future.

Co-authorship network of co-authors of David L. Sultzer

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Sultzer. A scholar is included among the top collaborators of David L. Sultzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Sultzer. David L. Sultzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bigio, Benedetta, Ricardo A. S. Lima‐Filho, Felipe Kenji Sudo, et al.. (2025). Sex differences in mitochondrial free-carnitine levels in subjects at-risk and with Alzheimer’s disease in two independent study cohorts. Molecular Psychiatry. 30(6). 2573–2583. 2 indexed citations

Koek, Ralph J., Josué M. Avecillas-Chasín, Scott E. Krahl, et al.. (2024). Deep brain stimulation of the amygdala for treatment-resistant combat post-traumatic stress disorder: Long-term results. Journal of Psychiatric Research. 175. 131–139. 10 indexed citations

Salazar, Christian R., et al.. (2024). Community recruitment of underrepresented populations to the AHEAD 3‐45 preclinical AD trial using novel partnerships with nursing and community‐based organizations: Lessons and outcomes. Alzheimer s & Dementia. 20(10). 7160–7173. 2 indexed citations

Kirn, Dylan, Joshua D. Grill, Paul Aisen, et al.. (2023). Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment. Alzheimer s Research & Therapy. 15(1). 88–88. 2 indexed citations

Sultzer, David L., et al.. (2017). Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging. American Journal of Geriatric Psychiatry. 25(4). 342–353. 24 indexed citations

Ismail, Zahinoor, Luis Agüera-Ortíz, Henry Brodaty, et al.. (2017). The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations. Journal of Alzheimer s Disease. 56(3). 929–938. 322 indexed citations breakdown →

Ismail, Zahinoor, Eric E. Smith, Yonas E. Geda, et al.. (2015). Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimer s & Dementia. 12(2). 195–202. 517 indexed citations breakdown →

Koek, Ralph J., Jean‐Philippe Langevin, Scott E. Krahl, et al.. (2014). Deep brain stimulation of the basolateral amygdala for treatment-refractory combat post-traumatic stress disorder (PTSD): study protocol for a pilot randomized controlled trial with blinded, staggered onset of stimulation. Trials. 15(1). 356–356. 49 indexed citations

Sultzer, David L., et al.. (2013). Neurobiology of Delusions, Memory, and Insight in Alzheimer Disease. American Journal of Geriatric Psychiatry. 22(11). 1346–1355. 31 indexed citations

10.

Vigen, Cheryl, Wendy J. Mack, Richard S.E. Keefe, et al.. (2011). Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD. American Journal of Psychiatry. 168(8). 831–839. 178 indexed citations

11.

Sultzer, David L., et al.. (2011). Solanezumab for Alzheimer's disease. Expert Opinion on Biological Therapy. 11(6). 787–798. 40 indexed citations

12.

Mohamed, Somaia, Robert A. Rosenheck, Constantine G. Lyketsos, et al.. (2011). Effect of Second-Generation Antipsychotics on Caregiver Burden in Alzheimer’s Disease. The Journal of Clinical Psychiatry. 73(1). 121–128. 19 indexed citations

13.

Schneider, Lon S., Cheryl Vigen, Wendy J. Mack, et al.. (2009). O4‐04‐01: Citalopram compared to atypical antipsychotics for Alzheimer patients who did not previously benefit from treatment: The catie‐AD study. Alzheimer s & Dementia. 5(4S_Part_5). 8 indexed citations

14.

McMurtray, Aaron, et al.. (2008). Content-Specific Delusions From Right Caudate Lacunar Stroke: Association with Prefrontal Hypometabolism. Journal of Neuropsychiatry. 20(1). 62–67. 23 indexed citations

15.

Sultzer, David L., Sonia M. Davis, Pierre N. Tariot, et al.. (2008). Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial. American Journal of Psychiatry. 165(7). 844–854. 207 indexed citations

16.

Marshall, Gad A., Lorena Monserratt, Dylan G. Harwood, et al.. (2007). Positron Emission Tomography Metabolic Correlates of Apathy in Alzheimer Disease. Archives of Neurology. 64(7). 1015–1015. 165 indexed citations

17.

Bartzokis, George, Jeffrey L. Cummings, David L. Sultzer, et al.. (2003). White Matter Structural Integrity in Healthy Aging Adults and Patients With Alzheimer Disease. Archives of Neurology. 60(3). 393–393. 328 indexed citations

18.

Sultzer, David L.. (2003). Psychosis and Antipsychotic Medications in Alzheimer’s Disease: Clinical Management and Research Perspectives. Dementia and Geriatric Cognitive Disorders. 17(1-2). 78–90. 23 indexed citations

19.

Bartzokis, George, David L. Sultzer, Jeffrey L. Cummings, et al.. (2000). In Vivo Evaluation of Brain Iron in Alzheimer Disease Using Magnetic Resonance Imaging. Archives of General Psychiatry. 57(1). 47–47. 185 indexed citations

20.

Absher, John R., et al.. (1994). p(C) Analysis Facilitates Dementia Diagnosis. Medical Decision Making. 14(4). 393–402. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact